Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
24
2017
Nominations Open For Annual Rosalind Franklin Award Bergeson & Campbell, P.C.
Mar
23
2017
Medicinal Products: the EU and the US Mutually Recognize Manufacturing Standards K&L Gates
Mar
23
2017
Congresswoman Calls for Halting Importation of Brazilian Meat Keller and Heckman LLP
Mar
23
2017
FDA Grants One-Year Extension on Intended Use Rule Faegre Drinker
Mar
22
2017
SCCS Issues Final Opinion on Additional Coatings for Titanium Dioxide (Nano Form) as UV-Filter in Dermally Applied Cosmetic Products Bergeson & Campbell, P.C.
Mar
22
2017
USDA Warns Canada-EU Trade Agreement Could Impact US Alcohol Beverage Exports McDermott Will & Emery
Mar
22
2017
Even With History of Food Safety Disasters, Emails Show Perdue Fretted About Regulation MapLight
Mar
22
2017
Senator Pat Roberts Urges Trump Administration to Scrap Reconsideration of COOL: Country of Origin Labeling Keller and Heckman LLP
Mar
22
2017
Trump’s Ag Nominee Has Taken Almost $1 Million From Industry During Political Career MapLight
Mar
21
2017
Wyden’s C-THRU Act – Publicizing PBM Drug Rebate Data Mintz
Mar
21
2017
FDA May Simplify Produce Safety Rule’s Agricultural Water Standards Keller and Heckman LLP
Mar
21
2017
Implications of EU Ingredient Labeling Proposal for US Suppliers McDermott Will & Emery
Mar
21
2017
New Report Calls for Consistent Criteria to Identify EDCs Across All EU Laws Keller and Heckman LLP
Mar
20
2017
Federal Appeals Court Upholds Dismissal of Public Employee For Failing Random Drug Test Jackson Lewis P.C.
Mar
20
2017
Biologics Price Competition and Innovation Act Helps Amgen Gain Dismissal of Genentech Complaint Mintz
Mar
20
2017
GNC Slack Fill Settlement Keller and Heckman LLP
Mar
20
2017
Sonny Perdue to Testify Before Senate Agriculture Committee; USDA Funding Under President Trump’s “Skinny Budget” Squire Patton Boggs (US) LLP
Mar
18
2017
NIOSH Will Hold Public Meeting and Seeks Comments on Draft CIB on the Occupational Exposure Banding Process: Guidance for the Evaluation of Chemical Hazards Bergeson & Campbell, P.C.
Mar
17
2017
Drug Enforcement Administration Addition Of Marijuana Extracts To Schedule I Substance Category Sheds Light On The Ever-Expanding Arena Of Drugs In The Workforce Steptoe & Johnson PLLC
Mar
17
2017
Neste Renewable Diesel Reduces GHG Emissions By 6.7 Million Tons Bergeson & Campbell, P.C.
Mar
17
2017
FSIS Issues Updated Guidance Concerning Beef and Veal Slaughter Best Practices Keller and Heckman LLP
Mar
17
2017
Connecticut Court Upholds Admissibility of Diffusion Tensor Imaging Stark & Stark
Mar
17
2017
Are Biosimilars Really That Similar? The $40B Question IMS Legal Strategies
Mar
16
2017
21st Century Cures Act Developments: FDA Proposes Class II Device Exemptions Mintz
Mar
16
2017
Food Labeling: Natural Challenge Stayed Keller and Heckman LLP
Mar
15
2017
Federal Circuit Vacated a PTAB Finding of Obviousness Because, by Providing an Overly Broad Construction, the PTAB Read Key Limitations Out of the Claims Hunton Andrews Kurth
Mar
15
2017
A Prior Art Reference that Merely Suggests the Claimed Subject Matter Does Not Anticipate the Claims Hunton Andrews Kurth
Mar
15
2017
US Senate Introduces New CFIUS Legislation Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins